Publications by authors named "Victoria E Blake"
J Am Heart Assoc
August 2024
Article Synopsis
- A study assessed the real-world effectiveness of mavacamten for treating obstructive hypertrophic cardiomyopathy in a diverse patient population at Johns Hopkins HCM center, involving 66 patients.
- Over a median treatment duration of 9 months, 72% of patients experienced improved heart failure symptoms and significant reduction in left ventricular outflow tract obstruction after 6 months of treatment.
- The medication had no severe adverse events but was less effective in patients with a BMI of 35 kg/m² or higher; effectiveness and safety were consistent across racial groups.
